30 related articles for article (PubMed ID: 18309279)
1. Functional selection of hepatitis C virus envelope E2-binding Peptide ligands by using ribosome display.
Chen F; Zhao Y; Liu M; Li D; Wu H; Chen H; Zhu Y; Luo F; Zhong J; Zhou Y; Qi Z; Zhang XL
Antimicrob Agents Chemother; 2010 Aug; 54(8):3355-64. PubMed ID: 20479194
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic approaches for hepatitis C virus: protease inhibitors and polymerase inhibitors.
Kwo PY; Vinayek R
Gut Liver; 2011 Dec; 5(4):406-17. PubMed ID: 22195237
[TBL] [Abstract][Full Text] [Related]
3. Phage display of combinatorial peptide libraries: application to antiviral research.
Castel G; Chtéoui M; Heyd B; Tordo N
Molecules; 2011 Apr; 16(5):3499-518. PubMed ID: 21522083
[TBL] [Abstract][Full Text] [Related]
4. Selection of peptides binding to HCV e2 and inhibiting viral infectivity.
Hong HW; Lee SW; Myung H
J Microbiol Biotechnol; 2010 Dec; 20(12):1769-71. PubMed ID: 21193836
[TBL] [Abstract][Full Text] [Related]
5. A homogeneous, solid-phase assay for hepatitis C virus RNA-dependent RNA polymerase.
Wang YK; Rigat KL; Roberts SB; Gao M
Anal Biochem; 2006 Dec; 359(1):106-11. PubMed ID: 17054898
[TBL] [Abstract][Full Text] [Related]
6. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of interaction between NS3 and NS5B protein of classical swine fever virus by deletion of terminal sequences of NS5B.
Wang Y; Zhu Z; Wang P; Yu J; Wan L; Chen J; Xiao M
Virus Res; 2011 Mar; 156(1-2):98-106. PubMed ID: 21237222
[TBL] [Abstract][Full Text] [Related]
8. Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase.
Kukolj G; McGibbon GA; McKercher G; Marquis M; Lefèbvre S; Thauvette L; Gauthier J; Goulet S; Poupart MA; Beaulieu PL
J Biol Chem; 2005 Nov; 280(47):39260-7. PubMed ID: 16188890
[TBL] [Abstract][Full Text] [Related]
9. Selection and target-site mapping of peptides inhibiting HCV NS5B polymerase using phage display.
Kim MS; Park C; Lee JH; Myung H
J Microbiol Biotechnol; 2008 Feb; 18(2):328-33. PubMed ID: 18309279
[TBL] [Abstract][Full Text] [Related]
10. Use of phage display and polyvalency to design inhibitors of protein-protein interactions.
Mourez M; Collier RJ
Methods Mol Biol; 2004; 261():213-28. PubMed ID: 15064461
[TBL] [Abstract][Full Text] [Related]
11. Methods for mapping protease specificity.
Diamond SL
Curr Opin Chem Biol; 2007 Feb; 11(1):46-51. PubMed ID: 17157549
[TBL] [Abstract][Full Text] [Related]
12. Generation of bioactive peptides by biological libraries.
Mersich C; Jungbauer A
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):160-70. PubMed ID: 17644452
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
